NovaBay Pharmaceuticals Inc
NBY1.820USD
-0.120-6.19%
收盤 09/19, 16:00（美東）報價延遲15分鐘
10.59M總市值
4.57本益比TTM
關於 NovaBay Pharmaceuticals Inc 公司
NovaBay Pharmaceuticals, Inc. 從事傷口護理產品業務。該公司通過其 NeutroPhase 和 PhaseOne 品牌產品爲傷口護理市場生產和銷售其專有形式的次氯酸。NeutroPhase 和 PhaseOne 用於外科手術中的清潔和沖洗，以及治療傷口、燒傷、潰瘍和其他損傷。
公司簡介
公司代碼NBY
公司名稱NovaBay Pharmaceuticals Inc
上市日期Oct 26, 2007
CEOMr. David E. Lazar
員工數量14
證券類型Ordinary Share
年結日Oct 26
公司地址2000 Powell St Ste 1150
城市EMERYVILLE
上市交易所NYSE American Consolidated
國家United States of America
郵編94608-1804
電話15108998800
網址https://novabay.com/
公司代碼NBY
上市日期Oct 26, 2007
CEOMr. David E. Lazar
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
580.00
-0.34%
Mr. Mijia (Bob) Wu
Mr. Mijia (Bob) Wu
Director
Director
122.00
--
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
92.00
--
Mr. Yongxiang (Sean) Zheng
Mr. Yongxiang (Sean) Zheng
Director
Director
50.00
--
Ms. Julie Garlikov
Ms. Julie Garlikov
Independent Director
Independent Director
50.00
--
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
26.00
--
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. David E. Lazar
Mr. David E. Lazar
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
580.00
-0.34%
Mr. Mijia (Bob) Wu
Mr. Mijia (Bob) Wu
Director
Director
122.00
--
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
92.00
--
Mr. Yongxiang (Sean) Zheng
Mr. Yongxiang (Sean) Zheng
Director
Director
50.00
--
Ms. Julie Garlikov
Ms. Julie Garlikov
Independent Director
Independent Director
50.00
--
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
26.00
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
業務USD
名稱
營收
佔比
Avenova
8.67M
88.67%
Other products
1.07M
10.98%
Other revenue, net
34.00K
0.35%
NeutroPhase
0.00
0.00%
地區USD
名稱
營收
佔比
United States
9.78M
100.00%
業務
地區
業務USD
名稱
營收
佔比
Avenova
8.67M
88.67%
Other products
1.07M
10.98%
Other revenue, net
34.00K
0.35%
NeutroPhase
0.00
0.00%
股東統計
更新時間: 8月19日 週二
更新時間: 8月19日 週二
持股股東
股東類型
持股股東
持股股東
佔比
Poplar Point Capital Management LLC
17.52%
C2C Wealth Management, LLC
1.68%
Geode Capital Management, L.L.C.
0.58%
Rangeley Capital LLC
0.57%
Two Sigma Investments, LP
0.42%
其他
79.23%
持股股東
持股股東
佔比
Poplar Point Capital Management LLC
17.52%
C2C Wealth Management, LLC
1.68%
Geode Capital Management, L.L.C.
0.58%
Rangeley Capital LLC
0.57%
Two Sigma Investments, LP
0.42%
其他
79.23%
股東類型
持股股東
佔比
Hedge Fund
18.60%
Investment Advisor
1.75%
Investment Advisor/Hedge Fund
0.58%
Venture Capital
0.35%
Individual Investor
0.02%
其他
78.70%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
43
1.43M
24.52%
+210.59K
2025Q1
42
1.34M
22.96%
+376.59K
2024Q4
40
546.91K
11.19%
+390.20K
2024Q3
42
126.44K
2.60%
+79.02K
2024Q2
44
12.01K
0.89%
-33.08K
2024Q1
44
12.73K
1.48%
-22.10K
2023Q4
45
34.29K
18.48%
+25.73K
2023Q3
47
15.18K
15.11%
-444.00
2023Q2
47
9.53K
10.53%
-5.30K
2023Q1
51
13.02K
22.50%
-2.13K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Poplar Point Capital Management LLC
1.02M
17.54%
+19.91K
+1.99%
Jun 03, 2025
C2C Wealth Management, LLC
55.00K
0.95%
+4.10K
+8.05%
Mar 31, 2025
Geode Capital Management, L.L.C.
35.00K
0.6%
+1.97K
+5.95%
Mar 31, 2025
Two Sigma Investments, LP
17.47K
0.3%
-13.94K
-44.37%
Mar 31, 2025
XTX Markets LLC
19.85K
0.34%
+3.71K
+22.98%
Mar 31, 2025
Tower Research Capital LLC
5.46K
0.09%
+6.00
+0.11%
Mar 31, 2025
UBS Financial Services, Inc.
749.00
0.01%
+749.00
--
Mar 31, 2025
Hall (Justin M)
580.00
0.01%
-2.00
-0.34%
Mar 18, 2025
The Vanguard Group, Inc.
392.00
0.01%
--
--
May 31, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
公告日期
類型
比率
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
